Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
galantamine hydrobromide, Quantity: 20.504 mg (Equivalent: galantamine, Qty 16 mg)
Southern Cross Pharma Pty Ltd
Galantamine hydrobromide
Capsule, modified release
Excipient Ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; Gelatin; magnesium stearate; microcrystalline cellulose
Oral
28
(S4) Prescription Only Medicine
Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type
Visual Identification: opaque flesh-flesh size 2 hard gelatin capsule containing two round biconvex tablets; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-01-20